Outcome measures for artificial pancreas clinical trials: A consensus report

David M. Maahs, Bruce A. Buckingham, Jessica Castle, Ali Cinar, Edward R. Damiano, Eyal Dassau, J. Hans De Vries, Francis J. Doyle, Steven C. Griffen, Ahmad Haidar, Lutz Heinemann, Roman Hovorka, Timothy W. Jones, Craig Kollman, Boris Kovatchev, Brian L. Levy, Revital Nimri, David N. O'Neal, Moshe Philip, Eric RenardSteven J. Russell, Stuart A. Weinzimer, Howard Zisser, John W. Lum

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Research on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care. In this report, members of the JDRF Artificial Pancreas Project Consortium in collaboration with thewider AP community 1) advocate for the use of continuous glucose monitoring glucosemetrics as outcomemeasures in AP trials, in addition to HbA1c, and 2) identify a short set of basic, easily interpreted outcome measures to be reported in AP studies whenever feasible. Consensus on a broader range of measures remains challenging; therefore, reporting of additional metrics is encouraged as appropriate for individual AP studies or study groups. Greater consistency in reporting of basic outcome measures may facilitate the interpretation of study results by investigators, regulatory bodies, health care providers, payers, and patients themselves, thereby accelerating the widespread adoption of AP technology to improve the lives of people with type 1 diabetes.

Original languageEnglish (US)
Pages (from-to)1175-1179
Number of pages5
JournalDiabetes Care
Volume39
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Artificial Pancreas
Outcome Assessment (Health Care)
Clinical Trials
Type 1 Diabetes Mellitus
Health Personnel
Research Personnel
Technology
Glucose

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Maahs, D. M., Buckingham, B. A., Castle, J., Cinar, A., Damiano, E. R., Dassau, E., ... Lum, J. W. (2016). Outcome measures for artificial pancreas clinical trials: A consensus report. Diabetes Care, 39(7), 1175-1179. https://doi.org/10.2337/dc15-2716

Outcome measures for artificial pancreas clinical trials : A consensus report. / Maahs, David M.; Buckingham, Bruce A.; Castle, Jessica; Cinar, Ali; Damiano, Edward R.; Dassau, Eyal; Hans De Vries, J.; Doyle, Francis J.; Griffen, Steven C.; Haidar, Ahmad; Heinemann, Lutz; Hovorka, Roman; Jones, Timothy W.; Kollman, Craig; Kovatchev, Boris; Levy, Brian L.; Nimri, Revital; O'Neal, David N.; Philip, Moshe; Renard, Eric; Russell, Steven J.; Weinzimer, Stuart A.; Zisser, Howard; Lum, John W.

In: Diabetes Care, Vol. 39, No. 7, 01.07.2016, p. 1175-1179.

Research output: Contribution to journalArticle

Maahs, DM, Buckingham, BA, Castle, J, Cinar, A, Damiano, ER, Dassau, E, Hans De Vries, J, Doyle, FJ, Griffen, SC, Haidar, A, Heinemann, L, Hovorka, R, Jones, TW, Kollman, C, Kovatchev, B, Levy, BL, Nimri, R, O'Neal, DN, Philip, M, Renard, E, Russell, SJ, Weinzimer, SA, Zisser, H & Lum, JW 2016, 'Outcome measures for artificial pancreas clinical trials: A consensus report', Diabetes Care, vol. 39, no. 7, pp. 1175-1179. https://doi.org/10.2337/dc15-2716
Maahs DM, Buckingham BA, Castle J, Cinar A, Damiano ER, Dassau E et al. Outcome measures for artificial pancreas clinical trials: A consensus report. Diabetes Care. 2016 Jul 1;39(7):1175-1179. https://doi.org/10.2337/dc15-2716
Maahs, David M. ; Buckingham, Bruce A. ; Castle, Jessica ; Cinar, Ali ; Damiano, Edward R. ; Dassau, Eyal ; Hans De Vries, J. ; Doyle, Francis J. ; Griffen, Steven C. ; Haidar, Ahmad ; Heinemann, Lutz ; Hovorka, Roman ; Jones, Timothy W. ; Kollman, Craig ; Kovatchev, Boris ; Levy, Brian L. ; Nimri, Revital ; O'Neal, David N. ; Philip, Moshe ; Renard, Eric ; Russell, Steven J. ; Weinzimer, Stuart A. ; Zisser, Howard ; Lum, John W. / Outcome measures for artificial pancreas clinical trials : A consensus report. In: Diabetes Care. 2016 ; Vol. 39, No. 7. pp. 1175-1179.
@article{3bf9835f7019460eb948feaf940d2d5a,
title = "Outcome measures for artificial pancreas clinical trials: A consensus report",
abstract = "Research on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care. In this report, members of the JDRF Artificial Pancreas Project Consortium in collaboration with thewider AP community 1) advocate for the use of continuous glucose monitoring glucosemetrics as outcomemeasures in AP trials, in addition to HbA1c, and 2) identify a short set of basic, easily interpreted outcome measures to be reported in AP studies whenever feasible. Consensus on a broader range of measures remains challenging; therefore, reporting of additional metrics is encouraged as appropriate for individual AP studies or study groups. Greater consistency in reporting of basic outcome measures may facilitate the interpretation of study results by investigators, regulatory bodies, health care providers, payers, and patients themselves, thereby accelerating the widespread adoption of AP technology to improve the lives of people with type 1 diabetes.",
author = "Maahs, {David M.} and Buckingham, {Bruce A.} and Jessica Castle and Ali Cinar and Damiano, {Edward R.} and Eyal Dassau and {Hans De Vries}, J. and Doyle, {Francis J.} and Griffen, {Steven C.} and Ahmad Haidar and Lutz Heinemann and Roman Hovorka and Jones, {Timothy W.} and Craig Kollman and Boris Kovatchev and Levy, {Brian L.} and Revital Nimri and O'Neal, {David N.} and Moshe Philip and Eric Renard and Russell, {Steven J.} and Weinzimer, {Stuart A.} and Howard Zisser and Lum, {John W.}",
year = "2016",
month = "7",
day = "1",
doi = "10.2337/dc15-2716",
language = "English (US)",
volume = "39",
pages = "1175--1179",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "7",

}

TY - JOUR

T1 - Outcome measures for artificial pancreas clinical trials

T2 - A consensus report

AU - Maahs, David M.

AU - Buckingham, Bruce A.

AU - Castle, Jessica

AU - Cinar, Ali

AU - Damiano, Edward R.

AU - Dassau, Eyal

AU - Hans De Vries, J.

AU - Doyle, Francis J.

AU - Griffen, Steven C.

AU - Haidar, Ahmad

AU - Heinemann, Lutz

AU - Hovorka, Roman

AU - Jones, Timothy W.

AU - Kollman, Craig

AU - Kovatchev, Boris

AU - Levy, Brian L.

AU - Nimri, Revital

AU - O'Neal, David N.

AU - Philip, Moshe

AU - Renard, Eric

AU - Russell, Steven J.

AU - Weinzimer, Stuart A.

AU - Zisser, Howard

AU - Lum, John W.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Research on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care. In this report, members of the JDRF Artificial Pancreas Project Consortium in collaboration with thewider AP community 1) advocate for the use of continuous glucose monitoring glucosemetrics as outcomemeasures in AP trials, in addition to HbA1c, and 2) identify a short set of basic, easily interpreted outcome measures to be reported in AP studies whenever feasible. Consensus on a broader range of measures remains challenging; therefore, reporting of additional metrics is encouraged as appropriate for individual AP studies or study groups. Greater consistency in reporting of basic outcome measures may facilitate the interpretation of study results by investigators, regulatory bodies, health care providers, payers, and patients themselves, thereby accelerating the widespread adoption of AP technology to improve the lives of people with type 1 diabetes.

AB - Research on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care. In this report, members of the JDRF Artificial Pancreas Project Consortium in collaboration with thewider AP community 1) advocate for the use of continuous glucose monitoring glucosemetrics as outcomemeasures in AP trials, in addition to HbA1c, and 2) identify a short set of basic, easily interpreted outcome measures to be reported in AP studies whenever feasible. Consensus on a broader range of measures remains challenging; therefore, reporting of additional metrics is encouraged as appropriate for individual AP studies or study groups. Greater consistency in reporting of basic outcome measures may facilitate the interpretation of study results by investigators, regulatory bodies, health care providers, payers, and patients themselves, thereby accelerating the widespread adoption of AP technology to improve the lives of people with type 1 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84975852962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975852962&partnerID=8YFLogxK

U2 - 10.2337/dc15-2716

DO - 10.2337/dc15-2716

M3 - Article

C2 - 27330126

AN - SCOPUS:84975852962

VL - 39

SP - 1175

EP - 1179

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 7

ER -